Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.
3-day cluster buy June 30–July 2 at $5.68–$5.97/share. Now $6.02 (+2.7% vs avg $5.86). Hartree is a commodity trading firm; HDSN is a refrigerant gas recycler. July 2 tranche ($1.62M) filed July 6 per holiday-extension deadline. Hartree now holds ~11.8% of HDSN.
Purchased June 29, 2026 via Carlos & Andrea Alberini Trust at weighted avg $160.73/share (prices ranged $158.50–$161.34). Now $169.00 (+5.1% since buy). Director open-market purchase at near-term lows.
Purchased June 30 via Emerald Hill Ventures SA at $18.32/share (range $18.29–$18.32). Now $19.63 (+7.2% since buy). Simultaneous cluster: CEO Ron Bentsur also bought 12,500 shares at $20.00 ($250K). Oncology biotech with recent public offering.
First tranche: June 25–29 at ~$2.50 avg. Filed June 29. Second tranche (July 2 filing): 107,463 additional shares at ~$2.50 ($268,880), filed July 6. Combined BOLD purchases ~$983K. Stock at $2.50 (flat). Form 425 on file suggests a potential merger or strategic combination.
Purchased June 29–July 1 at $22.95–$24.98/share (avg $23.92). Now $24.49 (+2.4% since avg). CFO open-market buy is high-conviction signal. Filing deadline (July 1 last transaction + holiday) landed July 6.
Second Tang Capital tranche: June 30–July 2 at ~$2.50 avg. Filed July 6 (holiday-adjusted deadline for July 2 transactions). Stock at $2.50 (flat vs buy). See first BOLD entry for merger context.
CEO bought June 30 at exactly $20.00/share — likely tied to concurrent public offering at $20. Now $19.63 (-1.9%, slightly underwater). Part of NVCT cluster buy week alongside 10% owner Mosseri ($916K buy same day).
AIThe day in insider buying
SEC Form 4 Insider Scan — July 7, 2026
Scanned the last 24–48 hours of EDGAR Form 4 filings (Independence Day holiday weekend compressed the filing window: July 2 transactions were due July 6, the first business day after the July 3–5 holiday). 6 qualifying buys (≥ $250K, transaction type P) totalling ~$7.56M.
Context: EDGAR was backlogged from the July 4 holiday weekend. The effective filing window covered transactions from June 29–July 2, 2026, with filings due on or by July 6 (Monday). Direct EDGAR API access was blocked by proxy; data sourced from SEC-aggregator feeds (Investing.com, Quiver Quantitative, StockTitan, Benzinga).
Headline Filings
HDSN — Hartree Partners LP (10% Owner) bought 764,202 shares ≈ $4.48M at $5.86 avg (June 30–July 2); now $6.02 (++2.7% since buy). 3-day cluster buy; Hartree is a commodity trading/energy firm accumulating in a refrigerant gas recycler. (filing)
RH — Director Carlos Alberini (via Carlos & Andrea Alberini Trust) bought 11,388 shares ≈ $1.83M at $160.73 avg (June 29); now $169.00 (+5.1% since buy). Director buying at lows in a high-end home furnishing retailer; stock has recovered above the purchase price. (filing)
NVCT — 10% Owner Marlio Charles Mosseri (via Emerald Hill Ventures SA) bought 50,000 shares ≈ $916K at $18.32 (June 30); now $19.63 (+7.2% since buy). Cluster buy alongside CEO Ron Bentsur who also purchased $250K at $20.00/share. Nuvectis Pharma is a small oncology biotech. (filing)
BOLD — 10% Owner Tang Capital Management bought a combined $983,648 across two Form 4s: 286,333 shares at ~$2.50 avg (June 25–29, filed June 29) and 107,463 shares at ~$2.50 (June 30–July 2, filed July 6). Stock now at $2.50 (flat vs. avg buy price). Boundless Bio is a small-cap oncology biotech; Form 425 suggests a business combination in process. (filing 1) (filing 2)
FTH — CFO Brian C. Stephenson bought 13,634 shares ≈ $326K at $23.92 avg (June 29–July 1, filed July 6); now $24.49 (+2.4% since avg buy). CFO open-market buys in a small biotech are generally a high-conviction signal. (filing via Investing.com)
Watch: Fiserv (FISV) Cluster Buy + Catalyst
Not in the strict 24h window, but noteworthy: following CEO Mike Lyons' abrupt departure on June 15, 2026, four Fiserv insiders purchased a combined ~$1.07M in shares at $49.33–$50.59 (mid-June filings). FISV closed Monday July 6 at $51.78 and is indicated +7.5% premarket on July 7 following a Reuters report that Fiserv is exploring the sale of its STAR debit card network to major banks (JPMorgan, BofA, Wells Fargo). Insiders who bought at the dip are now up ~+9–12%.
Notes
Holiday compression: July 3 (observed) + July 4–5 weekend = no trading or filings. All significant purchase filings from the July 2 trading day landed on July 6.
Sector themes: Oncology biotech (NVCT + BOLD cluster) and refrigerant gas/environmental services (HDSN) dominate the buy list. The Tang Capital BOLD buys are particularly notable given the Form 425 suggesting a potential merger or strategic combination.
HDSN is the largest single name by dollar value; Hartree's continued accumulation (now ~11.8% stake) over multiple days signals a disciplined, thesis-driven position build rather than a one-off trade.
RH director buy at ~$161 suggests insider views on the luxury home goods cycle; stock has bounced to $169.
Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.
SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's
stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what
average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free,
and a new scan is posted every trading day. How to read insider buying →
See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.